Cargando…
The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
Monoclonal antibodies are currently used in the diagnosis of gynecologic malignancies by way of immunohistochemical assays, serum assays, and in situ radiolocalization of carcinoma lesions. Among them is MAb B72.3, generated against a human tumor-associated antigen (TAG-72). Using immunohistochemica...
Autores principales: | Simpson, J., Schlom, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yale Journal of Biology and Medicine
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590270/ https://www.ncbi.nlm.nih.gov/pubmed/3055701 |
Ejemplares similares
-
Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice.
por: Turner, A., et al.
Publicado: (1994) -
A 72 kD trophoblast glycoprotein defined by a monoclonal antibody.
por: Hole, N., et al.
Publicado: (1988) -
A humanized monoclonal antibody that inhibits platelet‐surface ERp72 reveals a role for ERp72 in thrombosis
por: Holbrook, L.‐M., et al.
Publicado: (2018) -
Monoclonal Antibodies in Gynecological Cancer: A Critical Point of View
por: Bellati, Filippo, et al.
Publicado: (2011) -
MON-723 Identification of Thyrotrope Signature Genes and Regulatory Elements
por: Daly, Alexandre, et al.
Publicado: (2020)